PAVmed (PAVM) Long-Term Investments (2024 - 2025)
PAVmed's quarterly Long-Term Investments came in at $34.1 million in Q4 2025, up 33.09% year-on-year from $25.6 million in Q4 2024, and up 7.92% quarter-over-quarter from $31.6 million in Q3 2025.
PAVmed has reported Long-Term Investments for 2 years, with the latest figure at $34.1 million in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Investments rose 33.09% year-over-year to $34.1 million; the trailing twelve-month figure through Dec 2025 stood at $34.1 million (up 33.09% YoY), and the FY2025 full-year result was $34.1 million, up 33.09% from the prior year.
- Long-Term Investments for Q4 2025 stood at $34.1 million, up from $31.6 million in the prior quarter.
- The five-year high for Long-Term Investments was $46.6 million in Q1 2025, with the low at $25.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | 34.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.12 Mn |
| Sep 30, 2025 | 31.62 Mn |
| Jun 30, 2025 | 36.00 Mn |
| Mar 31, 2025 | 46.64 Mn |
| Dec 31, 2024 | 25.64 Mn |